Totaligent extends target closing date for Aetherium Medical acqui-hire to March 20, 2026

Totaligent, Inc.

Extension Amendment moves target date for definitive agreements and closing from March 5 to March 20, 2026.
Exclusivity period under the LOI remains in effect through April 5, 2026.
Previously disclosed LOI on Feb 12, 2026, for acqui-hire of Aetherium team and IP in exchange for equity.
Only the target timeline changed; all other LOI terms unchanged.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Totaligent, Inc. amended Extension Amendment with Aetherium Medical (effective 2026-03-04).

Action: amendment
Counterparty: Aetherium Medical
Effective: 2026-03-04

Exact text from the filing

On March 4, 2026, Totaligent, Inc. (the “Company”) entered into an Extension Amendment (the “Amendment”) to the Binding Letter of Intent dated February 11, 2026 (the “LOI”) with Aetherium Medical (“Aetherium”).

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

Totaligent, Inc. filing history →

Source: SEC EDGAR

accession 0001477932-26-001167

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.